Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters

Nucleic Acids Research

Volumn 42, Issue 12, 2014, Pages 7666-7680

  Loughery, Jayne ^a   Cox, Miranda ^a   Smith, Linda M ^a   Meek, David W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HISTONE; PROTEIN P21; PROTEIN P53; SERINE;

AMINO ACID SUBSTITUTION; ARTICLE; CDKN1A GENE; CELL STIMULATION; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; GENE; GENE EXPRESSION; GROWTH DISORDER; HISTONE ACETYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; TRANSACTIVATION;

CELL LINE, TUMOR; CHROMATIN; DNA DAMAGE; ETOPOSIDE; HUMANS; IMIDAZOLES; MUTATION; PHOSPHORYLATION; PIPERAZINES; PROMOTER REGIONS, GENETIC; SERINE; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84903977636     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku501     Document Type: Article

References (55)

1. Toledo, F.,Wahl, G.M. (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer, 6, 909-923.
2. Vousden, K.H., Lane, D.P. (2007) p53 in health and disease. Nat. Rev. Mol. Cell. Biol., 8, 275-283.
3. Hu, W., Feng, Z., Levine, A.J. (2012) The regulation of multiple p53 stress responses is mediated through MDM2. Genes Cancer, 3, 199-208.
4. Espinosa, J.M. (2008) Mechanisms of regulatory diversity within the p53 transcriptional network. Oncogene, 27, 4013-4023.
5. Murray-Zmijewski, F., Slee, E.A., Lu, X. (2008) A complex barcode underlies the heterogeneous response of p53 to stress. Nat. Rev. Mol. Cell. Biol., 9, 702-712.
6. Kruse, J.P., Gu, W. (2009) Modes of p53 regulation. Cell, 137, 609-622.
7. Meek, D.W. (2009) Tumour suppression by p53: a role for the DNA damage response? Nat. Rev. Cancer, 9, 714-723.
8. Meek, D.W., Anderson, C.W. (2009) Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb. Perspect. Biol., 1, a000950.
9. Jones, R.G., Plas, D.R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M.J., Thompson, C.B. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell, 18, 283-293.
10. Dornan, D., Hupp, T.R. (2001) Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300. EMBO Rep., 2, 139-144.
11. Dumaz, N., Meek, D.W. (1999) p53-serine15 phosphorylation stimulates transactivation function but does not directly influence interaction with HDM2. EMBO J., 18, 7002-7010.
12. Lambert, P.F., Kashanchi, F., Radonovich, M.F., Shiekhattar, R., Brady, J.N. (1998) Phosphorylation of p53 serine 15 increases interaction with CBP. J. Biol. Chem., 273, 33048-33053.
13. Ito, A., Kawaguchi, Y., Lai, C.H., Kovacs, J.J., Higashimoto, Y., Appella, E., Yao, T.P. (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J., 21, 6236-6245.
14. Sakaguchi, K., Herrera, J.E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C.W., Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev., 12, 2831-2841.
15. Dumaz, N., Milne, D.M., Meek, D.W. (1999) Protein kinase CK1 is a p53 threonine-18 protein kinase which requires prior phosphorylation of serine 15. FEBS Lett., 463, 312-316.
16. Saito, S., Goodarzi, A.A., Higashimoto, Y., Noda, Y., Lees-Miller, S.P., Appella, E., Anderson, C.W. (2002) ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem., 277, 12491-12494.
17. Saito, S., Yamaguchi, H., Higashimoto, Y., Chao, C., Xu, Y., Fornace, A.J. Jr, Appella, E., Anderson, C.W. (2003) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem., 278, 37536-37544.
18. Sakaguchi, K., Saito, S., Higashimoto, Y., Roy, S., Anderson, C.W., Appella, E. (2000) Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J. Biol. Chem., 275, 9278-9283.
19. Feng, H., Jenkins, L.M., Durell, S.R., Hayashi, R., Mazur, S.J., Cherry, S., Tropea, J.E., Miller, M., Wlodawer, A., Appella, E. et al. (2009) Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure, 17, 202-210.
20. Jenkins, L.M., Yamaguchi, H., Hayashi, R., Cherry, S., Tropea, J.E., Miller, M., Wlodawer, A., Appella, E., Mazur, S.J. (2009) Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry, 48, 1244-1255.
21. Lee, C.W., Arai, M., Martinez-Yamout, M.A., Dyson, H.J., Wright, P.E. (2009) Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. Biochemistry, 48, 2115-2124.
22. Polley, S., Guha, S., Roy, N.S., Kar, S., Sakaguchi, K., Chuman, Y., Swaminathan, V., Kundu, T., Roy, S. (2008) Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains. J. Mol. Biol., 376, 8-12.
23. Teufel, D.P., Bycroft, M., Fersht, A.R. (2009) Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2. Oncogene, 28, 2112-2118.
24. Cox, M.L., Meek, D.W. (2010) Phosphorylation of serine 392 in p53 is a common and integral event during p53 induction by diverse stimuli. Cell. Signal., 22, 564-571.
25. de Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A.V., Prives, C., Roussel, M.F., Sherr, C.J., Lowe, S.W. (1998) E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev., 12, 2434-2442.
26. Thompson, T., Tovar, C., Yang, H., Carvajal, D., Vu, B.T., Xu, Q., Wahl, G.M., Heimbrook, D.C., Vassilev, L.T. (2004) Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J. Biol. Chem., 279, 53015-53022.
27. Armata, H.L., Garlick, D.S., Sluss, H.K. (2007) The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression. Cancer Res., 67, 11696-11703.
28. Sluss, H.K., Armata, H., Gallant, J., Jones, S.N. (2004) Phosphorylation of serine 18 regulates distinct p53 functions in mice. Mol. Cell. Biol., 24, 976-984.
29. Halazonetis, T.D., Gorgoulis, V.G., Bartek, J. (2008) An oncogene-induced DNA damage model for cancer development. Science, 319, 1352-1355.
30. Donner, A.J., Szostek, S., Hoover, J.M., Espinosa, J.M. (2007) CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol. Cell, 27, 121-133.
31. Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M., Gannon, F. (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763.
32. Kaeser, M.D., Iggo, R.D. (2002) Chromatin immunoprecipitation analysis fails to support the latency model of regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. U. S. A., 99, 95-100.
33. Lakin, N.D., Hann, B.C., Jackson, S.P. (1999) The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53. Oncogene, 18, 3989-3995.
34. Siliciano, J.D., Canman, C.E., Taya, Y., Sakaguchi, K., Appella, E., Kastan, M.B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev., 11, 3471-3481.
35. Tibbetts, R.S., Brumbaugh, K.M., Williams, J.M., Sarkaria, J.N., Cliby, W.A., Shieh, S.-Y., Taya, Y., Prives, C., Abraham, R.T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev., 13, 152-157.
36. Lin, J., Chen, J., Elenbaas, B., Levine, A.J. (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev., 8, 1235-1246.
37. Rocha, S., Martin, A.M., Meek, D.W., Perkins, N.D. (2003) p53 represses cyclin D1 transcription through down-regulation of Bcl-3 and inducing increased association of the p52 NFkappaB subunit with histone deacetylase 1. Mol. Cell. Biol., 23, 4713-4727.
38. Vassilev, L.T., Vu, B.T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C. et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science, 303, 844-848.
39. Jenkins, L.M., Durell, S.R., Mazur, S.J., Appella, E. (2012) p53 N-terminal phosphorylation: a defining layer of complex regulation. Carcinogenesis, 33, 1441-1449.
40. Espinosa, J.M., Verdun, R.E., Emerson, B.M. (2003) p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol. Cell, 12, 1015-1027.
41. Joerger, A.C., Fersht, A.R. (2008) Structural biology of the tumor suppressor p53. Annu. Rev. Biochem., 77, 557-582.
42. Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., Gu, W. (2012) Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell, 149, 1269-1283.
43. Huang, W.C., Ju, T.K., Hung, M.C., Chen, C.C. (2007) Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol. Cell, 26, 75-87.
44. Gayther, S.A., Batley, S.J., Linger, L., Bannister, A., Thorpe, K., Chin, S.F., Daigo, Y., Russell, P., Wilson, A., Sowter, H.M. et al. (2000) Mutations truncating the EP300 acetylase in human cancers. Nature Genet., 24, 300-303.
45. Dey, A., Wong, E.T., Bist, P., Tergaonkar, V., Lane, D.P. (2007) Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy. Cell Cycle, 6, 2178-2185.
46. Espinosa, J.M., Emerson, B.M. (2001) Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell, 8, 57-69.
47. Bargonetti, J., Reynisdottir, I., Friedman, P.N., Prives, C. (1992) Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev., 6, 1886-1898.
48. Cain, C., Miller, S., Ahn, J., Prives, C. (2000) The N terminus of p53 regulates its dissociation from DNA. T J. Biol. Chem., 275, 39944-39953.
49. Cui, F., Zhurkin, V.B. (2014) Rotational positioning of nucleosomes facilitates selective binding of p53 to response elements associated with cell cycle arrest. Nucleic Acids Res., 42, 836-847.
50. Aloni-Grinstein, R., Shetzer, Y., Kaufman, T., Rotter, V. (2014) p53: The barrier to cancer stem cell formation. FEBS Lett., doi:10.1016/j.febslet.2014. 02.011.
51. Lin, T., Chao, C., Saito, S., Mazur, S.J., Murphy, M.E., Appella, E., Xu, Y. (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression.Nat. Cell Biol., 7, 165-171.
52. Liu, D., Ou, L., Clemenson, G.D. Jr., Chao, C., Lutske, M.E., Zambetti, G.P., Gage, F.H., Xu, Y. (2010) Puma is required for p53-induced depletion of adult stem cells.Nat. Cell Biol., 12, 993-998.
53. Nguyen, T.-A., Menendez, D., Resnick, M.A., Anderson, C.W. (2014) Mutant TP53 posttranslational modifications: challenges and opportunities. Human Mut., 35, 738-755.
54. Dehart, C.J., Chahal, J.S., Flint, S.J., Perlman, D.H. (2014) Extensive post-translational modification of active and inactivated forms of endogenous p53. Mol. Cell. Proteom., 13, 1-17.
55. Appella, E., Anderson, C.W. (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem., 268, 2764-2772.